Advertisement
Screener

RECURSION PHARMACEUTICALS, INC. (RXRX) ROA

RECURSION PHARMACEUTICALS, INC. (RXRX) ROA

  • 2026-06-30: ROA -42.79%.
  • 2026-03-31: ROA -41.79%.
  • 2025-12-31: ROA -43.74%.
  • 2025-09-30: ROA -51.13%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-42.79%
2026-03-31-41.79%
2025-12-31-43.74%
2025-09-30-51.13%
2025-06-30-49.84%
2025-03-31-44.04%
2024-12-31-32.01%
2024-09-30-52.00%
2024-06-30-48.32%
2024-03-31-63.48%
2023-12-31-50.19%
2023-09-30-46.38%
2023-06-30-39.00%
2023-03-31-39.66%
2022-12-31-34.15%
2022-09-30-40.38%
2022-06-30-34.78%
2022-03-31-28.84%
2021-12-31-30.55%
2021-09-30-22.37%
2021-06-30-17.72%
2021-03-31-36.51%
2020-12-31-29.14%

Annual ROA

DateROA
2025-12-31-43.74%
2024-12-31-32.01%
2023-12-31-50.19%
2022-12-31-34.15%
2021-12-31-30.55%
2020-12-31-29.14%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16
Vericel Corp (VCEL)United States$2.011B93.97
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Greenland Mines Ltd (GRML)United States$2.362B
NOVAVAX INC (NVAX)United States$1.748B-6.26
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51